Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

High-throughput screening assays for the identification of chemical probes.

Inglese J, Johnson RL, Simeonov A, Xia M, Zheng W, Austin CP, Auld DS.

Nat Chem Biol. 2007 Aug;3(8):466-79. Review.

PMID:
17637779
2.

Image-based chemical screening.

Carpenter AE.

Nat Chem Biol. 2007 Aug;3(8):461-5. Review.

PMID:
17637778
3.

High throughput assay technologies for ion channel drug discovery.

Zheng W, Spencer RH, Kiss L.

Assay Drug Dev Technol. 2004 Oct;2(5):543-52. Review.

PMID:
15671652
4.

[High throughput pharmacology for drug discovery].

Ozaki H, Imaizumi Y, Oishi K, Kohama K.

Nihon Yakurigaku Zasshi. 2001 Sep;118(3):187-96. Review. Japanese.

PMID:
11577459
5.

Use of high-content analysis for compound screening and target selection.

Rausch O.

IDrugs. 2005 Jul;8(7):573-7. Review.

PMID:
15973566
6.

G-protein coupled receptor assays: to measure affinity or efficacy that is the question.

Williams C, Sewing A.

Comb Chem High Throughput Screen. 2005 Jun;8(4):285-92. Review.

PMID:
16101004
7.

Technological advances in high-throughput screening.

Liu B, Li S, Hu J.

Am J Pharmacogenomics. 2004;4(4):263-76. Review.

PMID:
15287820
8.

HTS technologies in biopharmaceutical discovery.

Wu G, Doberstein SK.

Drug Discov Today. 2006 Aug;11(15-16):718-24. Review.

PMID:
16846799
9.

Synergies of virtual screening approaches.

Muegge I.

Mini Rev Med Chem. 2008 Aug;8(9):927-33. Review.

PMID:
18691150
10.

Adapting high-throughput screening methods and assays for biocontainment laboratories.

Rasmussen L, Tigabu B, White EL, Bostwick R, Tower N, Bukreyev A, Rockx B, LeDuc JW, Noah JW.

Assay Drug Dev Technol. 2015 Jan-Feb;13(1):44-54. doi: 10.1089/adt.2014.617. Review.

11.

High content cellular screening.

Rausch O.

Curr Opin Chem Biol. 2006 Aug;10(4):316-20. Epub 2006 Jun 21. Review.

PMID:
16793326
12.

Current status of virtual screening as analysed by target class.

Stoermer MJ.

Med Chem. 2006 Jan;2(1):89-112. Review.

PMID:
16787359
13.

Chemical proteomics and its application to drug discovery.

Jeffery DA, Bogyo M.

Curr Opin Biotechnol. 2003 Feb;14(1):87-95. Review.

PMID:
12566007
14.

Considerations for target validation and industrial approaches.

Plata-Salamán CR, Ilyin SE.

Methods Mol Biol. 2007;361:299-309. Review.

PMID:
17172719
15.

Introduction of the high throughput screening system.

Li Y.

Chin Med Sci J. 2001 Sep;16(3):179-81. Review.

PMID:
12899335
16.

Tackling the chemogenomic space by novel screening technologies.

Mayr LM.

Ernst Schering Res Found Workshop. 2006;(58):111-73. Review.

PMID:
16709002
17.

Fluorescence readouts in HTS: no gain without pain?

Gribbon P, Sewing A.

Drug Discov Today. 2003 Nov 15;8(22):1035-43. Review.

PMID:
14690634
18.

A review of basic principles of fractals and their application to pharmacokinetics.

Marsh RE, Riauka TA, McQuarrie SA.

Q J Nucl Med Mol Imaging. 2008 Sep;52(3):278-88. Review.

19.

Affinity-based screening techniques for enhancing lead discovery.

Comess KM, Schurdak ME.

Curr Opin Drug Discov Devel. 2004 Jul;7(4):411-6. Review.

PMID:
15338950
20.

Which aspects of HTS are empirically correlated with downstream success?

Bender A, Bojanic D, Davies JW, Crisman TJ, Mikhailov D, Scheiber J, Jenkins JL, Deng Z, Hill WA, Popov M, Jacoby E, Glick M.

Curr Opin Drug Discov Devel. 2008 May;11(3):327-37. Review.

PMID:
18428086

Supplemental Content

Support Center